Jatinder Lamba
机构: University of Florida
每年引用次数
引用次数
引用: 13,405
H-指数: 50
I10-指数 : 101
出版物: 250
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia
Bhise , Elsayed , Cao , Pounds
Genes 10 ( 4) 319
3
2019
Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.
J K Lamba , S Pounds , X Cao , J R Downing
Leukemia 23 ( 2) 402 -404
28
2009
Impact of Genetic Variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study
A K Mitra , K Crews , S Pounds , X Cao
Leukemia 25 ( 8) 1354 -1356
14
2011
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours
A Khatri , B W Williams , J Fisher , R C Brundage
British Journal of Cancer 110 ( 2) 304 -312
12
2014
Genome-wide association analysis identified genetic markers associated with triptolide cellular sensitivity using HapMap LCLs as model system.
Jatinder K lamba , Tanya Feldberg , Taraswi Mitra Ghosh , Neha Bhise
Cancer Research 73 ( 8_Supplement) 2214 -2214
1
2013
ABCB1 rs1045642 C>T Change Is Associated with AML Cell Line Sensitivity to Calicheamicin
Roya Rafiee , Soheil Meshinchi , Jatinder K Lmaba ,
Blood 132 1364 -1364
2018
Integrated Genome Wide Association Study (GWAS) Identifies SNPs Associated with Outcome in Pediatric AML
Abdelrahman H Elsayed , Huiyun Wu , Xueyuan Cao , Soheil Meshinchi
Blood 132 2758 -2758
2018
Pediatric LSC3 (pLSC3) Score Derived from DNMT3B-CD34-GPR56 As a Prognostic Tool to Predict AML Patient Outcome: Results from Two Independent Pediatric AML Cohorts
Abdelrahman H Elsayed , Huiyun Wu , Xueyuan Cao , Susana C. Raimondi
Blood 132 290 -290
2018
Metabolomics Profiling Reveals Markers for Chemosensitivity and Clinical Outcomes in Pediatric AML Patients
Bradley Stockard , Huiyun Wu , Joy D. Guingab , Timothy J. Garrett
Blood 132 1536 -1536
2
2018
Identification of suitable reference genes for hepatic microRNA quantitation
Vishal Lamba , Yogita Ghodke-Puranik , Weihua Guan , Jatinder K Lamba
BMC Research Notes 7 ( 1) 129 -129
41
2014
An Ara-C, Daunorubicin, and Etoposide microRNA (ADEmiR) Score As a Prognostic Tool to Predict AML Treatment Outcomes
Nam K Nguyen , Abdelrahman H Elsayed , Soheil Meshinchi , Jatinder K Lamba
Blood 136 7 -7
2020
Identification of Pharmacogenomic Single Nucleotide Polymorphism Variants As Contributors to Toxicity Phenotype in the Treatment of Acute Childhood Leukemia
Trisha Larkin , Abdelrahman H Elsayed , Roya Rafiee , Natasha Emanuel
Blood 136 25 -26
2020
Pharmacogenetics of the constitutive androstane receptor.
Jatinder K Lamba
Pharmacogenomics 9 ( 1) 71 -83
28
2008
Metabolomic Profiling Defines Distinct Metabolic Signature Associated with FLT3/ITD AML
Bradley Stockard , Timothy Garrett , Soheil Meshinchi , Jatinder K Lamba
Blood 128 ( 22) 1692 -1692
2016
CD33 Splicing Polymorphism Is a Strong Predictor of Therapeutic Efficacy of Gemtuzumab Ozogamicin in De Novo AML: Report from COG-AAML0531 Study
Jatinder K Lamba , Lata Chauhan , Michael R. Loken , Jessica Pollard
Blood 128 ( 22) 2743 -2743
2016
Genetic Variations in Calicheamicin Pathway Genes Are Predictors of Gemtuzumab Ozogamicin Response in AML Patients: Results from COG-AAML0531 Study
Jatinder K Lamba , Lata Chauhan , Richard Aplenc , Maggie Skrypek
Blood 126 ( 23) 1260 -1260
2015
Cflar Splicing SNP As Predictor of Chemo-Sensitivity to Anticancer Drugs
Lata Chauhan , Emilie J Bergsma , Jatinder K Lamba
Blood 126 ( 23) 2056 -2056
2015
Methylation of DNMT3B Strongly Associates with the Methylome, Cytogenetic Risk Groups, and Prognosis of Pediatric Acute Myeloid Leukemia
Jatinder K Lamba , Stanley Pounds , Xueyuan Cao , Susana C. Raimondi
Blood 126 ( 23) 2434 -2434
2015
Preliminary Lasso Regression Analysis Identifies DNA-Damage Gene Expression Signature Predictive of Clinical Outcomes in Patients Using Gemtuzumab Ozogamicin
Mohammed Gbadamosi , Abdelrahman H. Elsayed , Rhonda E. Ries , Soheil Meshinchi
Blood 134 1401 -1401
2019
Genome-Scale CRISPR-Cas9 Synthetic Lethal Screening of AML Cell Line Identified Functional Modulators of Etoposide Resistance Predictive of Clinical Outcome in AML Patients
Roya Rafiee , Amin Sobh , Abdelrahman H. Elsayed , Abderrahmane Tagmount
Blood 134 2685 -2685
1
2019